Abstract
Multiple sclerosis (MS) has been recognized as a distinct clinical entity for over 100 years, but its etiology remains elusive. In all likelihood, a viral infection during childhood or adolescence triggers an autoimmune response to oligodendrocytes and/or myelin in susceptible individuals (1). Patients with MS are now being treated with cyclophosphamide (2, 3), cyclosporine (4), azathioprine (5), whole body radiation (6, 7), or plasmapheresis (8), on the assumption that MS is an autoimmune disease. These therapies have potentially serious hematologic, gastrointestinal, infectious, or neoplastic side effects (9). Immunosuppressive therapy, even if effective in stabilizing multiple sclerosis, is less than ideal because of the above mentioned side effects. Establishment of the etiology of MS may allow for more earlier, more specific, and less toxic treatment. In this paper we will review the epidemiologic evidence for a viral etiology of MS, the current state of candidate viruses, viral associated human demyelinating diseases other than MS, and the animal models of viral-induced demyelination.
Chapter PDF
Similar content being viewed by others
Keywords
- MUltiple Sclerosis
- MUltiple Sclerosis Patient
- Progressive Multifocal Leukoencephalopathy
- Demyelinating Disease
- Progressive Multifocal Leukoencephalopathy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Waksman BH, Reingold SL: Viral etiology of multiple sclerosis. Wheredoes the truth lie? Trends in Neuroscience 9:388, 1986
Gonsdette RE, Delmotte P: Intensive immunosuppression with cyclophosphamide in multiple sclerosis: Follow-up of 116 patients for 2–6 years.J Neurol 173, 1977
Weiner HL, Hauser SL, Hafler DA, Fallis RJ, Lehrich JR, Dawson DM: The use of cyclophosphamide in the treatment of multiple sclerosis. Ann NY Acad Sci 436:373, 1985
Kappos L, Patzold V, Pommasch D, Poser S, Haas J, Krauseneck P, Malin JP, Fierz W, Graffensled B, Gugerli US: Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis. Results of the German Multicenter Study. Ann Neurol 23:56, 1988
Aimard G, Confavrev XC, Devic M: Long-term immunosuppressive treatment with azathioprine in multiple sclerosis: A 10 year trial with 77 patients. IN: Bauer HJ, Poser C, Ritter G (eds.): Progress in Multiple Sclerosis, New York, Springer-Verlag, 371, 1980
Hafstein MP, Devereux C, Tronno R, Zito G, Vidaver R, Dowling PC, Lavenhar M, Cook SD: Total lymphoid irradiation in chronic progressive multiple sclerosis: A preliminary report. NY Acad Sci 436:397, 1984
Hafstein MP, Devereux C, Troiano R, Hafstein MP, Hernandez E, Lavenhar M, Vidaver R, Dowling PC: Effect of total lymphoid irradiation in chronic progressive multiple sclerosis. Lancet 1:1405, 1986
Weiner HL, Dawson DM: Plasmapheresis in multiple sclerosis: Preliminary study. Neurology 30:1029, 1980
Hohlfeld R, Michels M, Heininger K, Besinger U, Toyka KV: Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. Neurology 38:253, 1988
Visscher BR, Clark VA, Detels R, Malingren RM, Valdiviezo NL, Dudley JP: Two populations with multiple sclerosis. Clinical and demographic characteristics. J Neurol 225:237, 1981
Kurtzke JF: Epidemiology of multiple sclerosis. IN: Hallpike JF, Adams CWM, Tourtellotte WN (eds). Multiple Sclerosis: Pathology, Diagnosis and Management. Baltimore, Williams and Wilkins, 47–95, 1983
Matthews WB: The pattern of disease. IN: Matthews WB, Acheson ED, Batchelor JR, Weiler RO (eds). McAlpine’s Multiple Sclerosis. Edinburgh, Churchill Livingston, 3–26, 1985
Acheson ED: Epidemiology of multiple sclerosis. Br Med Bull 33:9, 1977
Limburg CC: The geographic distribution of multiple sclerosis and estimated prevalence for the United States. Proc Assoc Res Nerv Ment Dis 28:15, 1950
Alter M, Leibowitz V, Speen J: Risk of multiple sclerosis related to age at immigration to Israel. Arcch Neurol 15:234, 1966
Kurtzke JF: A method for estimating the age at which immigration of white immigrants to South Africa with an example of its importance. S Afr Med J 1:663, 1970
Jersild C, Svejgaard A, Fog T: HLA antigens and multiple sclerosis. Lancet 1:1240, 1972
Naito S, Namerow N, Mickey MR, Terasaki PI: Multiple sclerosis: Association with HLA-A3. Tissue Antigens 2:1, 1972
Jersild C, Dupont B, Fog T, Platz PJ, Svejgard A: Histocompatibility determinants in multiple sclerosis. Transplant Rev 22:148, 1975
Fog T, Schuller E, Jersild C, Engelfriet CF, Bertrams J: Neurology. Multiple sclerosis. IN: Dausset J, Sveggaard A (eds). HLA and Disease. Copenhagen, Munksgaard, 108–109, 1977
Eldridge R, McFarland H, Seyer J, Sadowsby D, Krebs V: Familial multiple sclerosis: Clinical, histocompatibility and viral serological studies. Ann Neurol 3:75, 1978
Roberts DF, Roberts MJ, Poskanzer DC: Genetic analysis of multiple sclerosis in Orkney. J Epidem Comm Health 33:229, 1979
Ebers GC: Genetic factors in multiple sclerosis. Neurologic Clinics 1:645, 1983
Compston DAS, Vakarelis BM, Paul E, McDonald WI, Batchelor JR, Mims CA: Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 109:325, 1986
Bobowick AR, Kurtzke JF, Brody JA, Hrubec Z, Gillespie M: Twin study of multiple sclerosis: an epidemiologic inquiry. Neurology 28:978, 1978
Kurtzke JF, Hyllested K: Multiple sclerosis in the Faroe Islands : I. Clinical and epidemiological features. Ann Neurol 5:6, 1979
Kurtzke JF, Hyllested K: Multiple sclerosis in the Faroe Islands : III. An alternative assessment of the three epidemics. Acta Neurol Scan 76:317, 1987
Johnson RT: Viral infections of the nervous system. New York, Raven Press, 237–270, 1982
Haase AT, Ventura P, Gibbs CJ Jr, Tourtellotte WW: Measles virus nucleotide sequence: Detection by hybridization in situ. Science 212:672, 1981
Fraser NW, Lawrence WL, Wroblewska Z, Gilden DH, Koprowski H: Herpes simplex type I DNA in human brain tissue. Proc Natl Acad Sci 78:;6461, 1981
Tanaka R, Iwasaki Y, Koprowski H: Intracisternal virus-like particles in the brain of multiple sclerosis patients. J Neurol Sci 28:121, 1976
Adams JM, Imagawa DT: Measles antibodies in multiple sclerosis. Proc Soc Exp Bio Med 3:562, 1962
Norrby E: Viral antibodies in multiple sclerosis. Prog Med Virol 24:1, 1978
Haire M: Significance of virus antibodies. Br Med J 33:40, 1977
Cook SD, Dowling PC, Russell WC: Neutralizing antibodies to canine distemper virus and measles virus in multiple sclerosis. J Neurol Sci 41:61, 1979
Vandvic B, Degre M: Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders with special reference to measles antibody synthesis within the central nervous system. J Neurol Sci 24:201, 1975
Shirodaria PV, Haire M, Fleming E, Menett JD, Hawkins SA, Roberts SD: Viral antibody titers: Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol 44:1237, 1987
Koprowski H, DeFreitas EC, Harper ME, Sandberg-Wohlheim M, Sheremata WA, Robert-Guroff M, Saxinger CW, Feinberg MB, Wong-Staal F, Gallo RC: Multiple sclerosis and human T cell lymphotropic retroviruses. Nature 318:154, 1985
Ohta M, Ohta K, Mori F, Nishitani H, Saida T: Sera from patients with multiple sclerosis react with human T cell lymphotropic virus-1 gag proteins but not env proteins-Western blotting analysis. J Immunol 137:3440, 1986
Hauser SL, Aubert JS, Burks JS, Kerr C, Lyon-Caen 0, de The G, Brahic M: Analysis of human T lymphotropic virus sequences in multiple sclerosis tissue. Nature 322:176, 1986
Karpas A, Kampf U, Siden A, Koch M, Poser M: Lack of evidence for involvement of known human retroviruses in multiple sclerosis. Nature 322:177, 1986
Rice GPA, Armstrong A, Bulman DE, Paty DW, Ebers GC: Absence of antibody to HTLV-I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy. Ann Neurol 20:533, 1986
Birnbaum G, Aubitz S, Kotilinek L: Search for autonomously proliferating spinal fluid lymphocytes in patients with multiple sclerosis. Neurology 38:28, 1988
Kuroda Y, Shibasaki H, Sato H, Okochi K: Incidence of antibody to HTLV-I is not increased in Japanese MS patients. Neurology 37:156, 1987
Madden DI, Mundon FK, Tzam NR, Fuccillo DA, Dalakas MC, Calabrese V, Elizan TS, Sever JL: Serologic studies of MS patients, controls and patients with other neurologic diseases: Antibodies to HTLV-I, II, III. Neurology 38:81, 1988
Gessain A, Barin F, Vernant JC, Gout 0, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 2:407, 1985
Rodgers-Johnson P, Gajdusek DC, Morgano STC: HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet 2:1247, 1985
Osarne M, Usuko K, Izumo S. HTLV-I associated myelopathy, a new clinical entity: Lancet 1:1031, 1986
Osarne M, Matsumoto M, Usuku K, Izumo S, Igichi N, Anitani H, Tara M, Igata A: Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T cell leukemia-like cells. Ann Neurol 21:117, 1987
Vernant JC, Maurs L, Gessin A, Barin F, Gout 0, Delaporte JM, Sanhadjis K, Buisson G, de The G: Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type. A clinical and seroepidemiological study of 25 cases. Ann Neurol 21:123, 1987
Robertson WB, Cruickshank EK: Jamaican (tropical) myeloneuropathy. IN: Minckler J (ed). Pathology of the nervous system. New York, McGraw Hill, 2466–2476, 1972
Piccardo P, Ceroni M, Rodgers-Johnson P, Mora L, Asher DM, Char G, Gibbs CJ Jr, Gajdusek DC: Pathological and immunological observations on tropical spastic paraparesis in patients from Jamaica. Ann Neurol 23 : S156, 1988
Petito CK, Navia BA, Cho ES, Jordan BD, George DS, Price RW: Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Eng J Med 312:874, 1985
Levy RM, Bredesen DE, Rosenblum ML: Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature. J Neurosurg 62:475, 1985
Levy JA, Evans L, Chreg-Mayer C, Pan LZ, Lane A, Staben I, Dina D, Wiley C: The biologic and molecular properties of the AIDS-associated retrovirus on that affect antiviral therapy. Ann Inst Pasteur 138:101, 1987
Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 19:517, 1986
Navia BA, Cho ES, Petito CK, Price RW: The AIDS dementia complex: II. Neuropathology. Ann Neurol 19:525, 1986
McArthur JC, Johnson RT: Primary infection with human immunodeficiency virus. IN: Rosenblum JL, Levy RM, Bredesen DE (eds). AIDS and the nervous system. New York, Raven Press, 183–201, 1988
Padgett BL, Walker DL, ZuRhein GM: Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1:1257, 1971
Weiner LP, Herndon RM, Narayan 0: Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Eng J Med 286:385, 1972
Richardson EP Jr: Progressive multifocal leukoencephalopathy. IN: Vinken PJ, Bruyn GW (eds). Handbook of Clinical Neurology Vol 9. Multiple Sclerosis and Other Demyelinating Diseases. New York, Elsevier, 485–499, 1970
Miller JR, Barrett RE, Britton CB: Progressive multifocal leukoencephalopathy in a male homosexual with T cell immune deficiency. N Engl J Med 307:1436, 1982
Krupp LB, Lipton RB. Siverdlow ML, Leeds NE, Llena J: Progressive multifocal leukoencephalopathy: Clinical and radiographic features. Ann Neurol 17:344, 1985
Rosenblum ML, Levy RM, Bredesen DE: Overview of AIDS and the nervous system. IN: Rosenblum ML, Levy RM, Bredesen DE (eds).AIDS and the Nervous System. New York, Raven Press, 1–12, 1988
Fermaglich J, Hardman JM, Earle KM: Spontaneous progressive multifocal leukoencephalopathy. Neurology 20:479, 1970
Carroll BA, Lane B, Norman D: Diagnosis of progressive multifocal leukoencephalopathy by computerized tomography. Radiology 122:137, 1977
Brooks BR, Walker DL: Progressive multifocal leukoencephalopathy. Neurologic Clinics 2:299, 1984
ZuRhein GM: Polyoma-like virions in a human demyelinating disease. Acta Neuropathol 8:57, 1967
Aksamit AJ, Mourrain P, Sever JL, Major EO: Progressive multifocal leukoencephalopathy investigation of three cases using in situ hybridization with JC virus biotinylated DNA probe. Ann Neurol 18:490, 1985
Chesters PM, Heritage J, McCance DJ: Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Inf Dis 147:676, 1983
Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberto JR, Gitt J, Sarni N, Lux W: Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen on the pathogenesis of progressive multifocal leukoencephalopathy. N Eng J Med 318:301, 1988
Walker DL, Padgett BL, ZuRhein GM: Human papovavirus (JC) induction of brain tumors in hamsters. Science 181:674, 1973
Small JA, Scangos GA, Cork L, Jay G, Khoury G: The early region of human papovavirus: JC induces dysmyelination in transgenic mice. Cell 46:13, 1986
Trapp BD, Small JA, Pulley M, Khoury G, Scangos GA: Dysmyelination in transgenic mice containing JC virus early region. Ann Neurol 23:38, 1988
Stoner GL, Ryschkewitsch CF, Walker DL, Webster H de F: JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immunodeficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy. Proc NAtl Acad Sci 83:2271, 1986
Chan K-FJ, Stoner GL, Hashim GA, Huang K-P: Substrate specificity of rat brain calcium-activated and phospholipid-dependent protein kinase. Biochem Biophys Res Commun 134:1358, 1986
Stoner GL, Ryschkewitsch CF, Walker DL, Soffer D, Webster H de F: Immunocytochemical search for JC papovavirus large T-antigen in multiple sclerosis brain tissue. Acta Neuropath 70:345, 1986
Martin JR, Nathanson N: Animal models of virus-induced demyelination. Prog Neuropathol 4:27, 1979
Bailey OT, Pappenheimer AM, Sargent F, Cheever FS, Daniels JB: A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin: II. Pathol J Exp Med 90:195, 1949
Cheever FS, Daniels JB, Pappenheimer AM, Bailey OT: A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin: I. Isolation and biological properties of the virus. J Exp Med 90:181, 1949
Weiner LP: Pathogenesis of demyelination induced by mouse hepatitis virus (JHM virus). Arch Neurol 28:298, 1973
Stohlman SA, Freiinger JA: Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. I. Genetic analysis. Immunogenetics 6:277, 1978
Stohlman SA, Freiinger JA, Weiner LP: Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection. J Immunol 124:1733, 1980
Roos RP: Viruses and demyelination disease of the central nervous system. Neurology Clinics 1681, 1983
Herndon RM, Grifin DE, McCormick U, Weiner LP: Mouse hepatitis virus-induced recurrent demyelination: A preliminary report. Arch Neurol 32:32, 1975
Stohlman SA, Weiner LP: Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31:38, 1981
Haspel MN, Lampert PW, Oldstone MBA: Temperature sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc Natl Acad Sci 75:403, 1978
Knobler RL, Lampert PW, Oldstone MBA: Virus persistance and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298:279, 1982
Fleming JO, Trousdale MD, El-Zaatari FAK, Stohlman SA, Weiner LP: Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58:869, 1986
Nagashima K, Wege H, Meyermann R, ter Meulen V: Coronavirus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta Neuropathol 44:63, 1978
Wege H, Watanabe R, ter Meulen V: Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection. J Neuroimmunol 6:325, 1984
Watanabe R, Wege H, ter Meulen V: Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 305:150, 1983
Massa PT, Dorries R, Wege H, ter Meulen V: Analysis and pathogenetic significance of Class II MHC (la) antigen induction on astrocytes during JHM coronavirus infection in rats. IN: Lai MMC and Stohlman SA (eds). Coronaviruses, New York, Plenum Press, 203–218, 1987
Massa PT, Dorries R, ter Meulen V: Viral particles induce la antigen expression on astrocytes. Nature 320:543, 1987
Wisniewski H, Raine CS, Kay WJ: Observations on viral demyelinating encephalomyelitis. Canine distemper virus. Lab Invest 26:589, 1972
Raine CS: On the development of CNS lesions in natural canine distemper encephalomyelitis. J Neurol Sci 30:13, 1974
McCullough B, Krakowka S, Koestner A: Experimental canine distemper virus-induced demyelination. Lab Invest 31:216, 1974
Chew-Lim M, Cuckling AJ, Webb HE: Demyelination in mice after two or three infections with avirulent Semliki Forest virus. Vet Pathol 14:67, 1977
Tremain KE, Ikeda H: Physiological deficits in the visual system of mice infected with Semliki Forest virus and their correlation with those seen in patients with demyelinating disease. Brain 106:879, 1983
Tansey EM, Allen TGJ, Ikeda H: Enhanced retinal and optic nerve excitability associated with demyelination in mice infected with Semliki Forest virus. Brain 109:15, 1986
Fazakerley JK, Amor S, Webb HE: Reconstitution of Semliki Forest virus infected mice induces immune mediated pathological changes in the CNS. Clin Exp Immunol 52:15, 1983
Fazakerley JK, Webb HE: Semliki Forest virus-induced, immune mediated demyelination: The effect of radiation. Br J Exp Path 68:101, 1987
Fazakerley JK, Webb HE: Semliki Forest virus-induced, immunemediated demyelination. Adoptive transfer studies and viral persistence in nude mice. J Gen Virology 67:377, 1987
Kristensson K, Suennerkelm B, Persson L: Latent herpes simplex virus trigeminal ganglionic infection in mice and demyelination in the central nervous system. J Neurol Sci 43:253, 1979
Townsend JJ: The demyelinating effect of cornial HSV infection in normal and nude (athymic) mice. J Neurol Sci 50:435, 1981
Townsend JJ, Baringer JR: Morphology of central nervous system disease in immunosuppressive mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone. Lab Invest 40:178, 1979
Kastrukoff LF, Lau AS, Kim SJ: Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus Type I. Ann Neurol 22:52, 1987
Sigurdsson B: Rida, a chronic encephalitis of sheep. Br Vet J 110:341, 1954
Narayan 0, Griffin DE, Chase J: Antigenic drift of visna virus in persistently infected sheep. Science 197:376, 1977
Petursson G, Nathanson N, Georgsson G, Panitch H, Palsson PA: Pathogenesis of visna: I. Sequential virologic serologic and pathologic studies. Lab Invest 35:402, 1976
Nathanson N, Panitch H, Palson PA, Petersson G, Georgsson G: Pathogenesis of visna: II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest 35:444, 1976
Lipton HL: Theiler’s virus infection in mice: An unusual biphasic disease leading to demyelination. Infect Immun 11:1147, 1975
Brahic M, Stroop WG: Theiler’s virus persists in glial cells during demyelinating disease. Cell 26:123, 1981
Rodriguez M, Leibovitz JL, Lampert PW: Persistent infection of oligodendrocytes in Theiler’s virus-induced encephalomyelitis. Ann Neurol 13:426, 1983
Lipton HL, Dal Canto MC: Theiler’s virus-induced demyelination prevention by immunosuppression. Science 192:62, 1976
Roos RP, Firestone S, Wollmann R, Variakojes D, Arnason BGW: The effect of short-term and chronic immunosuppression on Theiler’s virus demyelination. J Neuroimmunol 2:223, 1982
Rauch HC, Montgomery IN, Hiriman CL, Harb W, Benjamins JA: Chronic Theiler’s virus infection in mice appearance of myelin basic protein in the cerebrospinal fluid and serum antibody directed against MBP. J Neuroimmunol 14:35, 1987
Lang W, Wiley C, Lampert P: Theiler’s virus encephalomyelitis is unaffected by treatment with myelin components. J Neuroimmunol 9:109, 1980
Bornstein MB, Miller A, Slagle S, Weitzman M, Crystal H, Drexler E, Keilson M, Mernam A, Wasser Theil-Smollers, Spada V, Weiss W, Arnon R, Jacobsohn I, Tertelbaum D, Sela M: A pilot trial of CoP-1 in exacerbating-remitting multiple sclerosis. N Eng J Med 317:408, 1977
Lipton HL: Persistent Theiler’s murine encephalomyelitis versus infection in mice depends on plaque size. J Gen Viral 46:169, 1980
Lipton HL, Melvold R: Genetic analysis of susceptibility to Theiler’s mice induced demyelinating disease in mice. J Immunol 132:1821, 1984
Clatch RJ, k Melvold R, Miller SD, Lipton HL: Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region. Correlation with TMEV-specific delayed-type hypersensitivity. J Immunol 135:1408, 1985
Clatch RJ, Melvold RW, Dal Canto MS, Miller SD, Lipton HL: The Theiler’s murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of murine equivalents of HLA-A, B, and C. J Neuroimmunol 15:121, 1987
Miller SD, Clatch RJ, Pevear DC, Trotter JL, Lipton HL: Class II restricted T cell responses in Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease: I. Cross specificity among TMEV substains and related picornaviruses, but not myelin proteins. J Immuno 138:3776, 1987
Love S, Wiley CA, Fujinami RS, Lampert PW: Effects of regional spinal x-radiation in demyelinating disease, caused by Theiler’s virus, mouse hepatitis virus or experimental allergic encephalomyelitis. J Neuroimmunology 14:19, 1987
Weiner LP, Johnson RT, Herndon RM: Viral infections and demyelinating disease. N Eng J Med 288:1103, 1973
Fujinami RS, Oldstone MBA: Amino acid homology and immune response between the encephalitogenic site of myelin basic protein and virus: A mechanism for autoimmunity. Science 230:1043, 198
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Shubin, R.A., Weiner, L.P. (1989). Viruses And Demyelination. In: Kim, S.U. (eds) Myelination and Demyelination. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0777-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0777-8_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8077-4
Online ISBN: 978-1-4613-0777-8
eBook Packages: Springer Book Archive